NDA 008248 · Baxter Hlthcare Corp
Wyamine Sulfate
Mephentermine Sulfate · Injection
DiscontinuedLast checked: Nov 20, 2026Latest source record: Feb 17, 1993 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1951
Dec 29, 1951
Approved uses
1
Original approval plus efficacy supplements
Registered trials
1
1 Phase 3, 0 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Dec 29, 1951 Original approval · Type 3 - New Dosage Form
2 products under this application
- WYAMINE SULFATE · MEPHENTERMINE SULFATE EQ 15MG BASE/ML · INJECTABLE, INJECTION · Discontinued
- WYAMINE SULFATE · MEPHENTERMINE SULFATE EQ 30MG BASE/ML · INJECTABLE, INJECTION · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Mephentermine" as an intervention, any sponsor and status, largest first.
KIST Medical and Teaching HospitalAcademic, hospital or other
NCT05706727 · 42 participants · Start Mar 23, 2023 · Primary completion Apr 29, 2024
Drug: Intravenous bolus dose of Mephentermine and mephentermine; intravenous bolus dose of phenylephrine 50 mcg · For: Hemodynamic Stability
Sites: Lalitpur, Nepal
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials.
Fitzgerald JP, Fedoruk KA, Jadin SM, et al. · Anaesthesia 2020 · Systematic Review, Network Meta-Analysis
- Comparison of phenylephrine hydrochloride and mephentermine sulphate for prevention of post spinal hypotension.
Mohta M, Janani SS, Sethi AK, et al. · Anaesthesia 2010 · Comparative Study, Randomized Controlled Trial
- Non-medical Mephentermine Use: A Systematic Review of Literature.
Patel V, Harsha, Kumar A, et al. · J Addict Med 2025 · Systematic Review
- Randomised trial of intravenous infusion of ephedrine or mephentermine for management of hypotension during spinal anaesthesia for Caesarean section.
Kansal A, Mohta M, Sethi AK, et al. · Anaesthesia 2005 · Clinical Trial, Comparative Study
- Vasopressor drugs for the prevention and treatment of hypotension during neuraxial anaesthesia for Caesarean delivery: a Bayesian network meta-analysis of fetal and maternal outcomes.
Singh PM, Singh NP, Reschke M, et al. · Br J Anaesth 2020 · Review, Network Meta-Analysis
- Efficacy of a mephentermine-based product as a vasopressor and a cardiac performance enhancer when given intramuscularly to cattle.
Cunha DNQ, Del Rio CL, Youngblood BL, et al. · J Vet Pharmacol Ther 2018 · Randomized Controlled Trial
Sponsor: Baxter Hlthcare Corp
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.